JP2010502210A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502210A5
JP2010502210A5 JP2009527228A JP2009527228A JP2010502210A5 JP 2010502210 A5 JP2010502210 A5 JP 2010502210A5 JP 2009527228 A JP2009527228 A JP 2009527228A JP 2009527228 A JP2009527228 A JP 2009527228A JP 2010502210 A5 JP2010502210 A5 JP 2010502210A5
Authority
JP
Japan
Prior art keywords
ovol1
stem cells
cancer stem
expression
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009527228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502210A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/003648 external-priority patent/WO2008029290A2/en
Publication of JP2010502210A publication Critical patent/JP2010502210A/ja
Publication of JP2010502210A5 publication Critical patent/JP2010502210A5/ja
Pending legal-status Critical Current

Links

JP2009527228A 2006-09-07 2007-09-07 遺伝子マーカーを使用する癌幹細胞の同定 Pending JP2010502210A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06018771 2006-09-07
PCT/IB2007/003648 WO2008029290A2 (en) 2006-09-07 2007-09-07 Identification of cancer stem cells using genetic markers

Publications (2)

Publication Number Publication Date
JP2010502210A JP2010502210A (ja) 2010-01-28
JP2010502210A5 true JP2010502210A5 (https=) 2010-10-28

Family

ID=39157635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009527228A Pending JP2010502210A (ja) 2006-09-07 2007-09-07 遺伝子マーカーを使用する癌幹細胞の同定

Country Status (5)

Country Link
US (1) US20100034736A1 (https=)
EP (1) EP2059613A2 (https=)
JP (1) JP2010502210A (https=)
CA (1) CA2662843A1 (https=)
WO (1) WO2008029290A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196905A1 (en) * 2009-01-30 2010-08-05 Kci Licensing, Inc. Adult Stem Cell Assays
KR101231235B1 (ko) 2010-04-21 2013-02-08 고려대학교 산학협력단 전립선암 줄기세포 선별용 단백질성 마커
KR101240199B1 (ko) 2010-04-26 2013-03-06 고려대학교 산학협력단 대장암 줄기세포 선별용 단백질성 마커
WO2013013222A1 (en) * 2011-07-21 2013-01-24 Veridex, Llc Assay to capture and detect circulating multiple myeloma cells from blood
CN103151461A (zh) 2013-02-27 2013-06-12 京东方科技集团股份有限公司 一种有机薄膜晶体管及其制备方法和制备装置
ES2651522T3 (es) 2013-12-16 2018-01-26 Humanitas Mirasole S.P.A. Altos niveles de FT de TEM para el diagnóstico del cáncer, en particular de cáncer colorrectal (CCR) y de páncreas (CP)
KR101805181B1 (ko) 2016-09-02 2017-12-07 충북대학교 산학협력단 인산화된 slug 단백질의 유사분열 세포에 대한 신규한 바이오 마커로서의 용도
MX2022001260A (es) * 2019-07-31 2022-04-18 Alector Llc Anticuerpos anti-ms4a4a y metodos de uso de los mismos.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195751B1 (es) * 2001-11-27 2005-04-01 Universidad De Salamanca (Otri) Mamiferos no humanos transgenicos como modelos para patologias humanas con origen en celulas stem.
CA2469204A1 (en) * 2001-12-07 2003-06-19 Regents Of The University Of Michigan Prospective identification and characterization of breast cancer stem cells
WO2003058201A2 (en) * 2001-12-31 2003-07-17 Quark Biotech, Inc. Methods for identifying marker genes for cancer
AU2003207708A1 (en) * 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
AU2003273542A1 (en) * 2002-05-31 2003-12-19 The Board Of Trustees Of The Leland Stanford Junior University Methods of identifying and isolating stem cells and cancer stem cells
US20040170605A1 (en) * 2003-02-27 2004-09-02 Garcia Isidro Sanchez Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications
US7927795B2 (en) * 2003-06-09 2011-04-19 Board Of Trustees Of The University Of Arkansas Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
JP2005000056A (ja) * 2003-06-11 2005-01-06 Sumitomo Pharmaceut Co Ltd ホルモン依存性癌疾患マーカー及びその利用
WO2006002378A2 (en) * 2004-06-23 2006-01-05 Avalon Pharmaceuticals Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
ES2301268B1 (es) * 2004-10-25 2009-05-01 Centro De Investigacion Biomolecular Aplicada Salamanca, S.L. Empleo del gen slug, o de sus productos de replicacion, transcripcion o expresion, en la identificacion, diagnostico, prevencion o tratamiento de la diseminacion del cancer y/o desarrollo de metastasis.
CA3218940A1 (en) * 2004-11-12 2006-05-18 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Similar Documents

Publication Publication Date Title
Kneitz et al. Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3
JP2010502210A5 (https=)
Jiang et al. Current prevalence status of gastric cancer and recent studies on the roles of circular RNAs and methods used to investigate circular RNAs
Ji et al. Identification of microRNAs specific for epithelial cell adhesion molecule–positive tumor cells in hepatocellular carcinoma
KR20190036553A (ko) 전이성 암의 치료 및 전이성 질환에 대한 모델 시스템
Pan et al. ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC)
Liu et al. The expression pattern of microRNAs and the associated pathways involved in the development of porcine placental folds that contribute to the expansion of the exchange surface area
Han et al. Whole transcriptome analysis of mesenchyme tissue in sika deer antler revealed the CeRNAs regulatory network associated with antler development
Wei et al. CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling
Zhang et al. SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p
WO2020093574A1 (zh) 一种肿瘤相关序列、长链非编码rna及其应用
JP6202659B2 (ja) 癌組織の不均一性マーカー及びその使用
Sun et al. miR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2
Wu et al. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway
JP2014207883A (ja) がん幹細胞及びその用途
He et al. Mtu1 defects are correlated with reduced osteogenic differentiation
Gao et al. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer
CN105969846A (zh) 一种长非编码rna及其在诊断/治疗非小细胞肺癌中的应用
Liu et al. Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR‐498 to promote proliferation and invasion of gastric cancer
CN105483246A (zh) 基因的差异表达在口腔癌诊断中的应用
US10221460B2 (en) Methods and kits for the prognosis and treatment of prostate cancer
Masalha et al. MiR-199a-3p induces mesenchymal to epithelial transition of keratinocytes by targeting RAP2B
Zhu et al. circGAPVD1 inhibits the progression of gastric cancer through miR-4424/STK4 axis and encoding GAPVD1-137aa protein
Axemaker et al. Normal uterine fibroblast are reprogramed into ovarian cancer-associated fibroblasts by ovarian tumor-derived conditioned media
CN114214430A (zh) Nkg2a在检测小鼠人源肿瘤模型中人nk细胞中的应用